Cantargia (Sweden) Performance
| CANTA Stock | SEK 1.84 0.03 1.66% |
The firm shows a Beta (market volatility) of 0.78, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cantargia's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cantargia is expected to be smaller as well. At this point, Cantargia AB has a negative expected return of -0.98%. Please make sure to confirm Cantargia's maximum drawdown, daily balance of power, period momentum indicator, as well as the relationship between the skewness and day typical price , to decide if Cantargia AB performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Cantargia AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
| Begin Period Cash Flow | 693.4 M | |
| Total Cashflows From Investing Activities | -102.4 M |
Cantargia |
Cantargia Relative Risk vs. Return Landscape
If you would invest 399.00 in Cantargia AB on August 28, 2024 and sell it today you would lose (215.00) from holding Cantargia AB or give up 53.88% of portfolio value over 90 days. Cantargia AB is generating negative expected returns and assumes 5.951% volatility on return distribution over the 90 days horizon. Simply put, 52% of stocks are less volatile than Cantargia, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Cantargia Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cantargia's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cantargia AB, and traders can use it to determine the average amount a Cantargia's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1644
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CANTA |
Estimated Market Risk
| 5.95 actual daily | 52 52% of assets are less volatile |
Expected Return
| -0.98 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cantargia is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cantargia by adding Cantargia to a well-diversified portfolio.
Cantargia Fundamentals Growth
Cantargia Stock prices reflect investors' perceptions of the future prospects and financial health of Cantargia, and Cantargia fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cantargia Stock performance.
| Return On Equity | -0.69 | |||
| Return On Asset | -0.4 | |||
| Current Valuation | 34.5 M | |||
| Shares Outstanding | 166.99 M | |||
| Price To Earning | 2.12 X | |||
| Price To Book | 1.11 X | |||
| EBITDA | (363.06 M) | |||
| Cash And Equivalents | 842.44 M | |||
| Cash Per Share | 8.41 X | |||
| Book Value Per Share | 2.87 X | |||
| Cash Flow From Operations | (346.44 M) | |||
| Earnings Per Share | (4.11) X | |||
| Total Asset | 600.24 M | |||
| Retained Earnings | (70 M) | |||
| Current Asset | 30 M | |||
| Current Liabilities | 9 M | |||
About Cantargia Performance
Assessing Cantargia's fundamental ratios provides investors with valuable insights into Cantargia's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Cantargia is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Cantargia AB , a biotechnology company, engages in the research and development of antibody-based treatments for life threatening diseases. Cantargia AB was founded in 2010 and is based in Lund, Sweden. Cantargia operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 19 people.Things to note about Cantargia AB performance evaluation
Checking the ongoing alerts about Cantargia for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cantargia AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cantargia AB generated a negative expected return over the last 90 days | |
| Cantargia AB has high historical volatility and very poor performance | |
| Cantargia AB may become a speculative penny stock | |
| Net Loss for the year was (370.27 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Cantargia AB has accumulated about 842.44 M in cash with (346.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.41, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Cantargia's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cantargia's stock is overvalued or undervalued compared to its peers.
- Examining Cantargia's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cantargia's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cantargia's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cantargia's stock. These opinions can provide insight into Cantargia's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Cantargia Stock Analysis
When running Cantargia's price analysis, check to measure Cantargia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cantargia is operating at the current time. Most of Cantargia's value examination focuses on studying past and present price action to predict the probability of Cantargia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cantargia's price. Additionally, you may evaluate how the addition of Cantargia to your portfolios can decrease your overall portfolio volatility.